Genmab A/S (CPH:GMAB)
Denmark · Delayed Price · Currency is DKK 2,044.00
-21.00 (-1.02%)
Oct 10, 2025, 4:59 PM CET
Genmab Market Cap
Genmab has a market cap or net worth of 125.82 billion as of October 10, 2025. Its market cap has increased by 23.25% in one year.
Market Cap
125.82B
Enterprise Value
108.34B
Revenue
23.16B
Ranking
n/a
PE Ratio
14.88
Stock Price
2,044.00
Market Cap Chart
Since October 18, 2000, Genmab's market cap has increased from 3.68B to 125.82B, an increase of 3,315.06%. That is a compound annual growth rate of 15.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 10, 2025 | 125.82B | 32.71% |
| Dec 30, 2024 | 94.81B | -32.65% |
| Dec 29, 2023 | 140.77B | -26.77% |
| Dec 30, 2022 | 192.23B | 11.72% |
| Dec 30, 2021 | 172.06B | 6.80% |
| Dec 30, 2020 | 161.11B | 67.11% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1,674.95B |
| Coloplast | 127.35B |
| Demant | 48.52B |
| ALK-Abelló | 47.16B |
| H. Lundbeck | 43.39B |
| Zealand Pharma | 35.07B |
| Ambu A/S | 27.46B |
| Bavarian Nordic | 18.32B |